Market experts are predicting more biopharma transactions in 2018 compared with last year, but positioning start-ups and emerging companies for the best deals is a tricky business. Scrip has collected advice from industry experts on how to value non-profit-making businesses and gathered tips on the best way to capture the attention of potential partners or buyers.
Albert Sokol, a partner at US law firm McDermott Will & Emery, highlights the challenges surrounding deal structures that include...








